(GuruFocus, October 13, 2009) Investment Guru Robert Olstein had an interview with Fox Business News. YTD his fund is up 30%, beating the S&P 500 by about 10%.
Here is the video:
Watch the latest business video atFOXBusiness.com
(click on this link to watch the interview if you don't see the video player)
When asked, top off his head, he likes heath care issues, not the insurance companies but the companies producing the disposables in the healthcare. He thinks the whatever the health care reform bill may end up with, more people will be accessible to health care, hence these companies will benefit. The portfolio now is 17-18% was in this kind of healthcare issues.
In particular, he mentioned two companies in the interview: Becton Dickinson and Co. (BDX, Financial) and Stryker Corporation (SYK, Financial)
Becton Dickinson and Co. (BDX)
Becton Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies devices and systems used by health care professionals, medical research institutions, and the general public. Becton Dickinson And Company has a market cap of $16.11 billion; its shares were traded at around $68.75 with a P/E ratio of 13.82 and P/S ratio of 2.25. The dividend yield of Becton Dickinson And Company stocks is 1.96%. Becton Dickinson And Company had an annual average earning growth of 10.8% over the past 10 years. GuruFocus rated Becton Dickinson And Company the business predictability rank of 4-star.
Accidentally, Berkshire Hathaway bought 1.2 million shares during the second quarter of 2009.
Stryker Corporation
Stryker Corporation develops manufactures and markets specialty surgical and medical products including orthopaedic implants bone, cement trauma systems used in bone repair, powered surgical instruments, endoscopic systems, craniomaxillofacial fixation devices, specialty surgical equipment used in neurosurgery and patient care and handling equipment for the global market and provide outpatient physical and occupational rehabilitation services. Stryker Corp. has a market cap of $17.46 billion; its shares were traded at around $45.52 with a P/E ratio of 15.47 and P/S ratio of 2.6. The dividend yield of Stryker Corp. stocks is 0.91%. Stryker Corp. had an annual average earning growth of 23.4% over the past 10 years. GuruFocus rated Stryker Corp. the business predictability rank of 4-star.
The company insiders seem to agree with Olstein:
GuruFocus provides real time information and insights of Investment Gurus such as Warren Buffett and Robert Olstein company insiders for Premium Members. If you are not a premium member, click here to sign up or upgrade. 7-Day Free Trial is available.
Watch an earlier (April 1, 2009) Bloomberg interview with Robert Olstein:
Here is the video:
(click on this link to watch the interview if you don't see the video player)
When asked, top off his head, he likes heath care issues, not the insurance companies but the companies producing the disposables in the healthcare. He thinks the whatever the health care reform bill may end up with, more people will be accessible to health care, hence these companies will benefit. The portfolio now is 17-18% was in this kind of healthcare issues.
In particular, he mentioned two companies in the interview: Becton Dickinson and Co. (BDX, Financial) and Stryker Corporation (SYK, Financial)
Becton Dickinson and Co. (BDX)
Becton Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies devices and systems used by health care professionals, medical research institutions, and the general public. Becton Dickinson And Company has a market cap of $16.11 billion; its shares were traded at around $68.75 with a P/E ratio of 13.82 and P/S ratio of 2.25. The dividend yield of Becton Dickinson And Company stocks is 1.96%. Becton Dickinson And Company had an annual average earning growth of 10.8% over the past 10 years. GuruFocus rated Becton Dickinson And Company the business predictability rank of 4-star.
Accidentally, Berkshire Hathaway bought 1.2 million shares during the second quarter of 2009.
Stryker Corporation
Stryker Corporation develops manufactures and markets specialty surgical and medical products including orthopaedic implants bone, cement trauma systems used in bone repair, powered surgical instruments, endoscopic systems, craniomaxillofacial fixation devices, specialty surgical equipment used in neurosurgery and patient care and handling equipment for the global market and provide outpatient physical and occupational rehabilitation services. Stryker Corp. has a market cap of $17.46 billion; its shares were traded at around $45.52 with a P/E ratio of 15.47 and P/S ratio of 2.6. The dividend yield of Stryker Corp. stocks is 0.91%. Stryker Corp. had an annual average earning growth of 23.4% over the past 10 years. GuruFocus rated Stryker Corp. the business predictability rank of 4-star.
The company insiders seem to agree with Olstein:
- Buy: Director Srikant Datar bought 1,000 shares of SYK stock on 08/28/2009 at the average price of $41; the price of the stock has increased by 11.02% since.
- Buy: Director Howard L Lance bought 3,000 shares of SYK stock on 08/10/2009 at the average price of $40.72; the price of the stock has increased by 11.79% since.
GuruFocus provides real time information and insights of Investment Gurus such as Warren Buffett and Robert Olstein company insiders for Premium Members. If you are not a premium member, click here to sign up or upgrade. 7-Day Free Trial is available.
Watch an earlier (April 1, 2009) Bloomberg interview with Robert Olstein:
